Alphatec now expects to end the year with $472 million in revenue, up from its second quarter prediction of $462 million, according to an Oct. 16 press release.
Its surgical revenue at the end of the quarter was between $103.3 million and $103.9 million, up from $102 million in quarter two.
Its total revenue reached $117.7 million to $118.5 million, up from $117 million in quarter two.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
